← Eichor
Study identifier: NCT06722222 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Gao's Triple Eversion Carotid Endarterectomy

Condition: Carotid Artery Stenosis  ·  Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University

PhaseN/A
Planned participants11
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

Carotid endarterectomy (CEA), an important surgical approach for managing carotid plaque, has evolved over more than 70 years but still cannot be applied to all tandem carotid lesions (TCLs) because of the wide range of these lesions. Herein, the investigators introduce an innovative CEA, Gao's triple eversion CEA (GTE-CEA), for the treatment of TCLs.

This description comes directly from the study's public registry record.

Talk to the study team

Jinren Zhou, Dr.  ·  15995090018  ·  2324050@zju.edu.cn

Zhiwei Gao, Dr.  ·  17357161850  ·  2317157@zju.edu.cn

Always discuss trial participation with your own doctor first.

Locations (1)

the Second Affiliated Hospital of Zhejiang University School of MedicineHangzhou, Zhejiang, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06722222